Vaxcyte, Inc. · NASDAQ:PCVX

Guggenhime Andrew sold 10,000 Vaxcyte, Inc. shares (Form 4)

Traded Jul 6, 2026 · Filed Jul 6, 2026

On Jul 6, 2026, Guggenhime Andrew (PRESIDENT AND CFO) sold 10,000 Vaxcyte, Inc. shares at an average US$57.29 for US$573K under a trading plan, leaving 104,395 shares. Filed Jul 6, 2026 (Form 4).

Sold
10,000 shares
Price
US$57.29 average (US$57.16 to US$57.76)
Value
US$573K
Holding after
104,395 shares
Trading plan
Yes (Made under a plan set in advance)
Role
PRESIDENT AND CFO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 6, 2026Common StockOption exercise10,000US$5.35114,395Direct
Jul 6, 2026Common StockSale7,913US$57.16106,482Direct
Jul 6, 2026Common StockSale2,087US$57.76104,395Direct

Source

View original at SEC

Related